Epidermal growth factor in saliva and serum of patients with cyclosporin-induced gingival overgrowth

Journal of Periodontal Research

Volumn 36, Issue 2, 2001, Pages 88-91

  Markopoulos, A K ^a   Belazi, M ^a   Drakoulakos, D ^b   Petrou americanou, C ^c   Sioulis, A ^d   Sakellari, D ^a   Papanayotou, P ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b State Hospital of Skin and Venereal Diseases   (Greece)

^c Research Associate   (Greece)

^d AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Cyclosporin; EGF; Gingival overgrowth; Saliva

Indexed keywords

CYCLOSPORIN; EPIDERMAL GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA BLEEDING; GINGIVA OVERGROWTH; GINGIVITIS; HUMAN; MALE; METABOLISM; NONPARAMETRIC TEST; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTITIS; SALIVA; STATISTICS; TOOTH PLAQUE;

CASE-CONTROL STUDIES; CYCLOSPORINE; DENTAL PLAQUE INDEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; SALIVA; STATISTICS; STATISTICS, NONPARAMETRIC;

EID: 0035321030     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2001.360204.x     Document Type: Article

References (26)

1. Calne RY, Rolles K. White DJG et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 34 kidneys, 2 pancreases and 2 livers. Lancer 1979;2:1033.
2. Belazi M, Thomopoulos GN, Markopoulos AK, Papanayotou P . Cyclosporin-induced gingival hyperplasia: ultrastructural study of the oral epithelial prickle cells. J Submicrosc Cytol Pathol 1993;25:591-601.
3. Chomette G, Auriol M, Szpirglas H et al. Essential and iatrogenic gingival hyperplasia. Its morphology and significance. Rev Stomatol Chir Maxillofac 1986;87:287-293.
4. Deliliers GL, Santoro F, Polli N et al. Light and electron microscopic study of cyclosporin A-induced gingival hyperplasia. J Periodontol 1986;57:771-775.
5. McGaw WT, Porter H. Cyclosporin-induced gingival over-growth: an ultrastructural stereologic study. Oral Surg Oral Med Oral Pathol 1988;65:186-190.
6. Rateitschak-Pluss EM, Hefti A, Lortsher R. Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
7. Rostock MH, Fry HR, Turner JH. Severe gingival over-growth associated with cyclosporin therapy. J Periodontol 1986;57:294-299.
8. Wysockie GP, Gretzinger HA, Laupacis A et al. Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
9. Yamasaki A, Rose GG, Pinero GJ, Mahan CL. Ultrastructure of fibroblasts in cyclosporin A-induced gingival hyperplasia. J Oral Pathol 1987;16:129-134.
10. Barka T. Biologically active polypeptides in submandibular glands. J Histochem Cytochem 1980;28:836-859.
11. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
12. Axelsson P, Lindhe J. Effects of fluoride on gingivitis and dental caries in a preventive program based on dental plaque control. Community Dent Oral Epidemiol 1975;3: 3156-3160.
13. Moderr T, Barr M, Dahlhof G. Periodontal disease in children with Down's syndrome. Scand J Dent Res 1990;98:228-234.
14. Ebersole JL, Taubman MA, Smith DJ, Goodson JM. Gingival crevicular fluid antibody to oral microorganisms. I. Method of collection and analysis of antibody. J Periodont Res 1984;19:124-132.
15. Malo C, Menard D. Influence of epidermal growth factor on the development of suckling mouse intestinal mucosa. Gastroenterology 1982;83:28-35.
16. Helmrath MA, Shin CA, Fox JW et al. Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis. Lancet 1998;351:266-267.
17. Maccini DM, Veit BC. Salivary epidermal factor in patients with and without acid peptic disease. Am J Gastroenterol 1990;85:1102-1104.
18. Borel JF, Feurer C, Mavnee C, Stahelin H. Effects of the new antilymphocyte peptide cyclosporin A in animals. Immunology 1977;32:1017-1025.
19. Bird G, Britton S. A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B-cell activator. Immunol Rev 1979;45:41-67.
20. Iacopino AM, Doxey D, Cutler CW et al. Phenytoin and cyclosporin A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:73-83.
21. Brown RS, Beaver WT, Bottomley WK. On the mechanism of drug-induced gingival hyperplasia. J Oral Pathol Med 1991;20:201-209.
22. Seymour RA, Heasman PA. Drugs and the periodontium. J Clin Periodontol 1988;15:1-16.
23. Modeer T, Andersson G. Regulation of epidermal growth factor receptor metabolism in gingival fibroblasts by phenytoin in nitro. J Oral Pathol Med 1990;19:188-191.
24. Modeer T, Mendez C, Dahllof G et al. Effect of phenytoin medication on the metabolism of epidermal growth factor receptor in cultured gingival fibroblasts. J Periodontol Res 1990;25:120-127.
25. Wrana JL, Sodek J, Ber RL, Bellows CG. The effect of platelet-derived transforming growth factor B on normal human diploid gingival fibroblasts. Eur J Biochem 1986; 159:69-76.
26. Navarro M, Mwsia R, Diez-Gibert O et al. Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women. Breast Cancer Res Treat 1997;42:83-86.